Basic Information
ANEUVO® is a platform and therapy development company focused on treating chronic injuries and conditions that cannot be cured by traditional pharmaceutical approaches. ExaStim®, a non-invasive neuromodulation system developed by ANEUVO, has received FDA Breakthrough Device Designation for the treatment of spinal cord injuries. ANEUVO's platform delivers therapeutic interventions to biological targets through both invasive and non-invasive methods to improve patient outcomes.